Searched for
DRUG AND DIAGNOSTICS DEVELOPMENT
These large- and mid-cap stocks may give more than 25% return in 1 year, according to analystsFor the last few earnings seasons, the message has been: “Show me growth, I have the money.” Stocks with better-than-expected earnings saw ...- Stock picks of the week: 5 stocks with consistent score improvement and upside potential of up to 27% in 1 yearAfter the correction, the street will reach a stage where, if a company delivers numbers, there will be enough money waiting to move into t...
- These large- and mid-cap stocks can give more than 20% return in 1 year, according to analystsHas a peace deal been agreed on by the US and Iran? Will the fragile ceasefire hold? No one can answer these questions with any certainty. ...
- India sends emergency medical supplies for Ebola outbreak response in CongoIndia has provided crucial pharmaceutical supplies to aid the fight against the Ebola outbreak in Congo. The Africa Centres for Disease Con...
- Long-term Investing: Ecosystem with an edge called India; 12 large- mid- and small-cap stocks with upside potential of up to 34%Tactical investing should not be confused with long-term investing. In a world where geopolitical risk, commodity shocks, and uncertainty a...
- These large-caps have ‘strong buy’ & ‘buy’ recos and an upside potential of up to 25%Here’s a thing investors in equity need to keep in mind. A large part of the upmove one might see in the next one or two trading sessions w...
- Alzheimer's a key part of Eli Lilly's India specialty medicine push, says company's country head Winselow TuckerEli Lilly has introduced Lormalzi in India, a pioneering treatment for Alzheimer's that specifically targets amyloid plaques, a significant...
- India should chart own path in treatment of rare diseases: ICMR chiefIndia is taking a groundbreaking step forward in the realm of rare disease care with a distinctive approach that champions local ingenuity ...
- These mid-cap stocks with ‘Strong Buy’ & ‘Buy’ recos can rally over 25%, according to analystsWhat we are witnessing in the market these days is similar to scenarios that have played out in the past. There have been many points in th...
- Stock picks of the week: 5 stocks with consistent score improvement and upside potential of up to 36%Whether you are a trader or an investor, there is one thing to watch carefully in the coming days: Earnings. The reason why this is importa...
- These mid-cap stocks with ‘Strong Buy’ & ‘Buy’ recos can rally over 25%, according to analystsWhat is evident in the last few trading sessions is how the street is treating Q4 earnings numbers. If a company delivers in terms of numbe...
- These large-caps have ‘strong buy’ & ‘buy’ recos and an upside potential of up to 25%It is tough to think positively about the markets when all the news is about blockades, wars, and everything that can disturb the global ec...
- Roche ramps up AI computing capacity with Nvidia chip expansionRoche said the additional hardware would speed up work across its research and development operations, including modelling, data analysis...
- Centre of Excellence at IIT Madras to develop biomarkers for early detection of pancreatic cancerThe Indian Institute of Technology (IIT), Madras has set up a Centre of Excellence to develop biomarkers for early detection of pancreatic ...
- Cipla launches diagnostic device for multiple health conditionsThe company said with the device the company has expanded its product offerings for diagnostics laboratories and aims to bridge the current...
- Lupin's foray into diagnostics appears a calculated riskThe under-performing pharma company's foray into a competitive services business like diagnostics may seem counter-intuitive, as Lupin has ...
- GenePath Diagnostics develops quantitative COVID-19 test kit for drug makersThe kit is currently being used by a couple of unidentified drug makers in India, said GenePath Diagnostics CEO Nickhil Jakatdar. He said t...
- 14 firms get license to evaluate COVID-19 tests kitsRoche Diagnostics India and other 13 Indian firms include CoSara Diagnostics from Ahmedabad and CPC Diagnostics from Chennai. All these com...
- Roche Diagnostics India first private firm to get COVID-19 test approvalSwiss firm Roche Diagnostics India received the license for conducting coronavirus tests after approval from drug regulator DCGI, making it...
- Global swine flu kit makers gear up to meet demandUS-based Applied Biosystems and Swiss firm Roche Diagnostics , have said that they are ramping up their manufacturing capacities to meet ri...
Load More
